Cargando…
The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature
BACKGROUND: Antenatally diagnosed sacrococcygeal teratoma has been associated with risks of perinatal complications and death, especially when the foetus has symptoms of cardiac insufficiency, hydrops or anemia in utero; however, the method of intervention remains controversial. CASE: A 25-year-old...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666771/ https://www.ncbi.nlm.nih.gov/pubmed/36408142 http://dx.doi.org/10.3389/fonc.2022.1035058 |
_version_ | 1784831583646121984 |
---|---|
author | Ding, Yunping Yang, Mengmeng Lv, Min Jiang, Ying Dong, Tian Zhao, Baihui Luo, Qiong |
author_facet | Ding, Yunping Yang, Mengmeng Lv, Min Jiang, Ying Dong, Tian Zhao, Baihui Luo, Qiong |
author_sort | Ding, Yunping |
collection | PubMed |
description | BACKGROUND: Antenatally diagnosed sacrococcygeal teratoma has been associated with risks of perinatal complications and death, especially when the foetus has symptoms of cardiac insufficiency, hydrops or anemia in utero; however, the method of intervention remains controversial. CASE: A 25-year-old pregnant woman was found to have a cystic and solid tumor in the fetal sacrococcygeal region at 16 weeks of gestation. As the tumour grew, the mother developed polyhydramnios accompanied with gestational diabetes. Fetal and tumorous hemodynamics were closely monitored by ultrasound. Abnormal cardiac function was detected at 31 weeks’ gestation, and we creatively performed pre-emptive delivery through the ex-utero intrapartum treatment with debulking. The teratoma was removed with utero-placental circulation support. The operation proceeded smoothly with favourable prognosis for both mother and newborn. CONCLUSION: The ex-utero intrapartum treatment may improve the prognosis for fetuses with heart failure when they reach viable gestation. |
format | Online Article Text |
id | pubmed-9666771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96667712022-11-17 The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature Ding, Yunping Yang, Mengmeng Lv, Min Jiang, Ying Dong, Tian Zhao, Baihui Luo, Qiong Front Oncol Oncology BACKGROUND: Antenatally diagnosed sacrococcygeal teratoma has been associated with risks of perinatal complications and death, especially when the foetus has symptoms of cardiac insufficiency, hydrops or anemia in utero; however, the method of intervention remains controversial. CASE: A 25-year-old pregnant woman was found to have a cystic and solid tumor in the fetal sacrococcygeal region at 16 weeks of gestation. As the tumour grew, the mother developed polyhydramnios accompanied with gestational diabetes. Fetal and tumorous hemodynamics were closely monitored by ultrasound. Abnormal cardiac function was detected at 31 weeks’ gestation, and we creatively performed pre-emptive delivery through the ex-utero intrapartum treatment with debulking. The teratoma was removed with utero-placental circulation support. The operation proceeded smoothly with favourable prognosis for both mother and newborn. CONCLUSION: The ex-utero intrapartum treatment may improve the prognosis for fetuses with heart failure when they reach viable gestation. Frontiers Media S.A. 2022-11-02 /pmc/articles/PMC9666771/ /pubmed/36408142 http://dx.doi.org/10.3389/fonc.2022.1035058 Text en Copyright © 2022 Ding, Yang, Lv, Jiang, Dong, Zhao and Luo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Ding, Yunping Yang, Mengmeng Lv, Min Jiang, Ying Dong, Tian Zhao, Baihui Luo, Qiong The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature |
title | The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature |
title_full | The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature |
title_fullStr | The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature |
title_full_unstemmed | The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature |
title_short | The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature |
title_sort | ex-utero intrapartum treatment (exit) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: a case report and review of the literature |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666771/ https://www.ncbi.nlm.nih.gov/pubmed/36408142 http://dx.doi.org/10.3389/fonc.2022.1035058 |
work_keys_str_mv | AT dingyunping theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT yangmengmeng theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT lvmin theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT jiangying theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT dongtian theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT zhaobaihui theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT luoqiong theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT dingyunping exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT yangmengmeng exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT lvmin exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT jiangying exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT dongtian exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT zhaobaihui exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature AT luoqiong exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature |